More on TFX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $124.26 |
|
|||
| Open | $124.77 | ||||
| 52 Wk High | $188.79 | ||||
| 52 Wk Low | $125.28 | ||||
| Day High | $127.61 | ||||
| Day Low | $124.77 | ||||
| P/E | 36.56 | ||||
| EPS | $3.46 | ||||
| Volume | 267,735 | ||||
- Teleflex starts global pivotal trial for resorbable magnesium scaffold
- Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
- Form 8-K TELEFLEX INC For: Jun 15
- Form 4 TELEFLEX INC For: Jun 07 Filed by: RANDLE STUART A
- Form 4 TELEFLEX INC For: Jun 08 Filed by: Weidman Jason R.
- Form 3 TELEFLEX INC For: Jun 08 Filed by: Weidman Jason R.
- Form 8-K TELEFLEX INC For: Jun 08
- Teleflex reports four-year study data on resorbable heart scaffold
- Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
- Piper Sandler Assumes Coverage and Upgrades Teleflex (TFX) to Overweight
Entities mentioned with TFX
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
